BIODESIX, INC. Adjustments to Additional Paid in Capital, Warrant Issued
BIODESIX, INC. (BDSX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.25 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-05
- BIODESIX, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-03-31 was $1.25M.
- BIODESIX, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-12-31 was $0.00.
- BIODESIX, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $0.00.
- BIODESIX, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $280.00K.
- BIODESIX, INC. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $280.00K.
- BIODESIX, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $2.91M.
- BIODESIX, INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $8.27M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.25M 10-Q · filed 2026-08-05 | $1.25M derived: sum of 2 quarters · filed 2026-08-05 | $1.25M derived: sum of 3 quarters · filed 2026-08-05 | $1.53M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $280.00K derived: sum of 3 quarters · filed 2026-08-05 | $280.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $280.00K derived: sum of 2 quarters · filed 2026-08-05 | $280.00K 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $280.00K 10-Q · filed 2026-08-05 | $280.00K 10-Q · filed 2026-08-05 | ||
| 2023-06-30 | $674.00K 10-Q · filed 2024-11-01 | |||
| 2022-12-31 | $2.91M 10-K · filed 2024-03-01 | |||
| 2020-12-31 | $8.27M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |